These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus. Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250 [TBL] [Abstract][Full Text] [Related]
11. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Janelsins MC; Mastrangelo MA; Park KM; Sudol KL; Narrow WC; Oddo S; LaFerla FM; Callahan LM; Federoff HJ; Bowers WJ Am J Pathol; 2008 Dec; 173(6):1768-82. PubMed ID: 18974297 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Tan ZS; Beiser AS; Vasan RS; Roubenoff R; Dinarello CA; Harris TB; Benjamin EJ; Au R; Kiel DP; Wolf PA; Seshadri S Neurology; 2007 May; 68(22):1902-8. PubMed ID: 17536046 [TBL] [Abstract][Full Text] [Related]
13. Acetyl Cholinesterase Inhibitors and Cell-Derived Peripheral Inflammatory Cytokines in Early Stages of Alzheimer's Disease. Kokras N; Stamouli E; Sotiropoulos I; Katirtzoglou EA; Siarkos KT; Dalagiorgou G; Alexandraki KI; Coulocheri S; Piperi C; Politis AM J Clin Psychopharmacol; 2018 Apr; 38(2):138-143. PubMed ID: 29420357 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers. Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825 [TBL] [Abstract][Full Text] [Related]
15. Increased production of inflammatory cytokines in mild cognitive impairment. Magaki S; Mueller C; Dickson C; Kirsch W Exp Gerontol; 2007 Mar; 42(3):233-40. PubMed ID: 17085001 [TBL] [Abstract][Full Text] [Related]
16. Targeting TNF: a therapeutic strategy for Alzheimer's disease. Cheng X; Shen Y; Li R Drug Discov Today; 2014 Nov; 19(11):1822-1827. PubMed ID: 24998784 [TBL] [Abstract][Full Text] [Related]
17. Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls. Cestari JA; Fabri GM; Kalil J; Nitrini R; Jacob-Filho W; de Siqueira JT; Siqueira SR J Alzheimers Dis; 2016 Apr; 52(4):1479-85. PubMed ID: 27104907 [TBL] [Abstract][Full Text] [Related]
18. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment. Kim YS; Lee KJ; Kim H Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814 [TBL] [Abstract][Full Text] [Related]
19. Novel systemic markers for patients with Alzheimer disease? - a pilot study. Kassner SS; Bonaterra GA; Kaiser E; Hildebrandt W; Metz J; Schröder J; Kinscherf R Curr Alzheimer Res; 2008 Aug; 5(4):358-66. PubMed ID: 18690833 [TBL] [Abstract][Full Text] [Related]
20. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease. Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N Curr Alzheimer Res; 2013 Feb; 10(2):174-9. PubMed ID: 23463936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]